VIA
VNDA icon

Virtus Investment Advisers’s Vanda Pharmaceuticals VNDA Stock Holding History

Virtus Investment Advisers’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-28,255
Closed -$133K – 408
2024
Q3 		$133K Hold
28,255
– – 0.1% 227
2024
Q2 		$160K Buy
+28,255
New +$146K 0.14% 204
2023
Q1 		– Sell
-10,908
Closed -$80.6K – 341
2022
Q4 		$80.6K Buy
+10,908
New +$106K 0.05% 287

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Virtus Investment Advisers's VNDA Position: Q4 2024 in Review

Virtus Investment Advisers sold out of Vanda Pharmaceuticals (VNDA) in Q4 2024, closing a stake of 28,255 shares — an estimated $133K sold.

Virtus Investment Advisers first reported a position in VNDA in Q4 2022 and held it in 3 quarters. The position peaked at $160K in Q2 2024. 146 funds tracked by Wall St. Rank hold VNDA as of Q4 2024.

  • Virtus Investment Advisers reported no remaining Vanda Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Virtus Investment Advisers sold 28,255 Vanda Pharmaceuticals shares in Q4 2024, an estimated $133K.
  • Virtus Investment Advisers first reported a position in Vanda Pharmaceuticals in Q4 2022 and held it in 3 quarters.
  • Virtus Investment Advisers's Vanda Pharmaceuticals position peaked at $160K in Q2 2024.
  • 146 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2024.

Based on Virtus Investment Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.